Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martha E Lopez-Burks

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|April 28, 2016
Genetic enhancement of limb defects in a mouse model of Cornelia de Lange syndromeMartha E Lopez-Burks, Rosaysela Santos, Shimako Kawauchi, et al.
Biorxiv : the Preprint Server for Biology|October 31, 2023
Gastrulation-stage gene expression in <i>Nipbl</i> <sup>+/-</sup> mouse embryos foreshadows the development of syndromic birth defectsStephenson Chea, Jesse Kreger, Martha E Lopez-Burks, et al.
Science Advances|March 20, 2024
Gastrulation-stage gene expression in <i>Nipbl</i><sup>+/-</sup> mouse embryos foreshadows the development of syndromic birth defectsStephenson Chea, Jesse Kreger, Martha E Lopez-Burks, et al.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|April 28, 2016
Using mouse and zebrafish models to understand the etiology of developmental defects in Cornelia de Lange SyndromeShimako Kawauchi, Rosaysela Santos, Akihiko Muto, et al.
Plos Genetics|September 26, 2014
Nipbl and mediator cooperatively regulate gene expression to control limb developmentAkihiko Muto, Shingo Ikeda, Martha E Lopez-Burks, et al.
Plos Biology|September 9, 2016
Conditional Creation and Rescue of Nipbl-Deficiency in Mice Reveals Multiple Determinants of Risk for Congenital Heart DefectsRosaysela Santos, Shimako Kawauchi, Russell E Jacobs, et al.
Plos Genetics|September 19, 2009
Multiple organ system defects and transcriptional dysregulation in the Nipbl(+/-) mouse, a model of Cornelia de Lange SyndromeShimako Kawauchi, Anne L Calof, Rosaysela Santos, et al.
Nature Methods|February 8, 2022
NTR 2.0: a rationally engineered prodrug-converting enzyme with substantially enhanced efficacy for targeted cell ablationAbigail V Sharrock, Timothy S Mulligan, Kelsi R Hall, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|April 28, 2016
Genetic enhancement of limb defects in a mouse model of Cornelia de Lange syndromeMartha E Lopez-Burks, Rosaysela Santos, Shimako Kawauchi, et al.
Biorxiv : the Preprint Server for Biology|October 31, 2023
Gastrulation-stage gene expression in <i>Nipbl</i> <sup>+/-</sup> mouse embryos foreshadows the development of syndromic birth defectsStephenson Chea, Jesse Kreger, Martha E Lopez-Burks, et al.
Science Advances|March 20, 2024
Gastrulation-stage gene expression in <i>Nipbl</i><sup>+/-</sup> mouse embryos foreshadows the development of syndromic birth defectsStephenson Chea, Jesse Kreger, Martha E Lopez-Burks, et al.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|April 28, 2016
Using mouse and zebrafish models to understand the etiology of developmental defects in Cornelia de Lange SyndromeShimako Kawauchi, Rosaysela Santos, Akihiko Muto, et al.
Plos Genetics|September 26, 2014
Nipbl and mediator cooperatively regulate gene expression to control limb developmentAkihiko Muto, Shingo Ikeda, Martha E Lopez-Burks, et al.
Plos Biology|September 9, 2016
Conditional Creation and Rescue of Nipbl-Deficiency in Mice Reveals Multiple Determinants of Risk for Congenital Heart DefectsRosaysela Santos, Shimako Kawauchi, Russell E Jacobs, et al.
Plos Genetics|September 19, 2009
Multiple organ system defects and transcriptional dysregulation in the Nipbl(+/-) mouse, a model of Cornelia de Lange SyndromeShimako Kawauchi, Anne L Calof, Rosaysela Santos, et al.
Nature Methods|February 8, 2022
NTR 2.0: a rationally engineered prodrug-converting enzyme with substantially enhanced efficacy for targeted cell ablationAbigail V Sharrock, Timothy S Mulligan, Kelsi R Hall, et al.
Pageof 1